DI-029 Use of erythropoiesis-stimulating agents after the cessation of supply of continuous erythrop...
DI-029 Use of erythropoiesis-stimulating agents after the cessation of supply of continuous erythropoietin receptor activator
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
More information
Scope and Contents
Contents
Background In 2012, due to a problem in manufacturing continuous erythropoietin receptor activator (CERA), the Spanish Health System issued an alert recommending not starting new treatments with this drug and replacing it by other erythropoiesis-stimulating agents (ESA) in patients already on treatment. Purpose To assess the dose and efficacy of th...
Alternative Titles
Full title
DI-029 Use of erythropoiesis-stimulating agents after the cessation of supply of continuous erythropoietin receptor activator
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2552746998
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552746998
Other Identifiers
ISSN
2047-9956
E-ISSN
2047-9964
DOI
10.1136/ejhpharm-2013-000436.200
